润达医疗(603108) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 was CNY 2,439,778,208.38, representing a year-on-year increase of 23.10%[4] - The net profit attributable to shareholders for Q3 2021 was CNY 118,518,484.50, showing a decrease of 4.86% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 115,660,238.59, a decrease of 2.69% year-on-year[4] - For the first nine months of 2021, the company achieved operating revenue of CNY 6,773,088,805.26, an increase of 37.53% compared to the same period last year[6] - The net profit attributable to shareholders for the first nine months of 2021 was CNY 325,510,480.22, reflecting a growth of 38.05% year-on-year[6] - The basic earnings per share for Q3 2021 was CNY 0.20, a decrease of 4.76% compared to the same period last year[5] - The diluted earnings per share for Q3 2021 was CNY 0.20, also down by 4.76% year-on-year[5] - The total comprehensive income for the third quarter of 2021 was approximately CNY 490.64 million, compared to CNY 354.38 million in the same period of 2020, representing an increase of about 38.4%[21] - Basic earnings per share for the third quarter of 2021 were CNY 0.56, up from CNY 0.41 in the same quarter of 2020, reflecting a growth of 36.6%[21] Assets and Liabilities - The total assets at the end of the reporting period were CNY 12,111,791,044.34, an increase of 19.02% compared to the end of the previous year[5] - Total assets as of Q3 2021 amounted to ¥12,111,791,044.34, an increase from ¥10,176,547,262.92 in the previous year[17] - Total liabilities reached ¥7,765,858,329.78 in Q3 2021, compared to ¥6,096,311,368.55 in Q3 2020, marking a 27.4% increase[17] - Total liabilities reached approximately $6.10 billion, a decrease of $99.68 million from the previous period[29] - Current liabilities totaled approximately $5.54 billion, showing a slight decrease of $38.25 million[29] Cash Flow - The company reported a net cash flow from operating activities of CNY -82,683,773.58 for the year-to-date, a decline of 158.68% year-on-year[6] - The net cash flow from operating activities for the third quarter of 2021 was negative CNY 82.68 million, a decline from a positive CNY 140.91 million in the same quarter of 2020[24] - Cash inflow from operating activities for the first three quarters of 2021 was CNY 7.07 billion, compared to CNY 5.57 billion in the same period of 2020, indicating an increase of approximately 26.9%[24] - Cash outflow from investing activities for the third quarter of 2021 totaled CNY 1.25 billion, down from CNY 2.05 billion in the same period of 2020, showing a decrease of about 39.0%[25] - The net cash flow from financing activities for the third quarter of 2021 was CNY 273.24 million, a decrease from CNY 832.89 million in the same quarter of 2020, reflecting a decline of approximately 67.2%[25] - The company reported a cash and cash equivalents balance of CNY 518.06 million at the end of the third quarter of 2021, down from CNY 605.15 million at the end of the same quarter in 2020[25] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 579,538,095[11] - The largest shareholder, Hangzhou Gongshu State-owned Investment Holding Group Co., Ltd., holds 116,000,000 shares, representing 20.02% of total shares[11] - The second-largest shareholder, Zhu Wenyi, holds 54,938,408 shares, accounting for 9.48% of total shares[11] - The company has no pledged or frozen shares among the top ten shareholders[11] Operational Insights - The report indicates that there are no significant changes in the company's operational situation during the reporting period[12] - The company plans to expand its market presence and invest in new technologies to drive future growth[20] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[21] Inventory and Receivables - Accounts receivable increased to approximately ¥3.80 billion from ¥3.01 billion year-over-year[14] - Inventory as of September 30, 2021, is approximately ¥1.47 billion, up from ¥1.15 billion at the end of 2020[14] - The company's goodwill increased to approximately ¥2.02 billion from ¥1.79 billion year-over-year[14] - The total current assets as of September 30, 2021, are approximately ¥7.58 billion, compared to ¥6.23 billion at the end of 2020[14] - Accounts receivable stood at approximately $3.01 billion, indicating stable collection performance[27] - Inventory was reported at approximately $1.15 billion, reflecting consistent stock levels[27]